SCHEMBL7429377

SCHEMBL7429377

CCOC(=O)c1ccsn1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.55
MAPT P10636 4/20 0.46
NPC1 O15118 3/20 0.46
RAB9A P51151 3/20 0.46
KMT2A Q03164 2/20 0.46
MEN1 O00255 1/20 0.46
ALDH1A1 P00352 1/20 0.46
POLB P06746 2/20 0.46
PKM P14618 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
RXFP1 Q9HBX9 1/20 0.46
TSHR P16473 1/20 0.46
CA12 O43570 2/20 0.43
CA1 P00915 2/20 0.43
CA2 P00918 2/20 0.43
CA7 P43166 2/20 0.43
CA9 Q16790 2/20 0.43
CA14 Q9ULX7 2/20 0.43
ESR1 P03372 1/20 0.43
ESR2 Q92731 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5642066 0.74 CYP1A2 (0.64) CYP1A2MAPTNPC1RAB9AKMT2A
SCHEMBL1478915 0.71 CYP1A2 (1.00) CYP1A2MAPTNPC1RAB9AKMT2A
SCHEMBL22609332 0.70 CYP1A2 (0.50) CYP1A2MAPTNPC1RAB9AKMT2A
SCHEMBL3702158 0.70 MAPT (0.61) CYP1A2MAPTNPC1RAB9AKMT2A
SCHEMBL1019601 0.70 CYP1A2 (0.59) CYP1A2MAPTNPC1RAB9AKMT2A
SCHEMBL17594962 0.69 CHEK2 (0.57) CYP1A2MAPTNPC1RAB9AKMT2A
SCHEMBL10735324 0.69 CYP4F2 (0.49) CYP1A2MAPTKMT2AMEN1ALDH1A1
SCHEMBL11565201 0.69 KDM4E (0.51) MAPTKMT2AMEN1ALDH1A1NPSR1
SCHEMBL159255 0.69 CYP1A2 (0.49) CYP1A2MAPTNPC1RAB9AKMT2A
SCHEMBL13197220 0.68 CYP1A2 (0.56) CYP1A2MAPTNPC1RAB9AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110818704-B Spiro bridged ring compounds, pharmaceutical compositions thereof and uses thereof 广州市恒诺康医药科技有限公司 2023-08-01 CN disclosed
WO-2020029908-A1 SPIRO BRIDGED RING COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF 广州市恒诺康医药科技有限公司 2020-02-13 WO disclosed
CN-101959882-A Imidazole carbonyl compound DAIICHI SANKYO CO LTD 2011-01-26 CN disclosed
EP-0986562-B1 SUBSTITUTED 1,2,4-TRIAZOLO 3,4-A]PHTHALAZINE DERIVATIVES AS GABA ALPHA 5 LIGANDS MERCK SHARP & DOHME (GB) 2002-08-07 EP disclosed
US-6310203-B1 Precursor compounds to substituted 1,2,4-triazolo[3,4,-a]phathalazine GABA alpha 5 ligands MERCK SHARPE & DOHME LIMITED (GB) 2001-10-30 US disclosed
US-6200975-B1 FOR COGNITION ENHANCEMENT THERAPY MERCK SHARP & DOHME LIMITED (GB) 2001-03-13 US disclosed
EP-0986562-A1 SUBSTITUTED 1,2,4-TRIAZOLO 3,4-A]PHTHALAZINE DERIVATIVES AS GABA ALPHA 5 LIGANDS MERCK SHARP & DOHME LTD. (GB) 2000-03-22 EP disclosed
WO-1998050385-A1 SUBSTITUTED 1,2,4-TRIAZOLO[3,4-a]PHTHALAZINE DERIVATIVES AS GABA ALPHA 5 LIGANDS MERCK SHARP & DOHME LIMITED (GB) 1998-11-12 WO disclosed